Enhancer ID: | E_01_0602 |
Species: | human |
Position : | chr1:207877984-207879984 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 32478125 |
Enhancer experiment: | GUIDE-Seq?rhAmpSeq |
Enhancer experiment description: | Notably, similar editing improvement was observed when excess gRNA over Cas9 protein was used, providing a DNAfree alternative suitable for therapeutic applications. |
Target gene : | CD34 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Notably, similar editing improvement was observed when excess gRNA over Cas9 protein was used, providing a DNAfree alternative suitable for therapeutic applications. |
TF name : | -- |
TF experiment: | GUIDE-Seq?rhAmpSeq |
TF experiment description: | Notably, similar editing improvement was observed when excess gRNA over Cas9 protein was used, providing a DNAfree alternative suitable for therapeutic applications. |
Enhancer function : | Notably, similar editing improvement was observed when excess gRNA over Cas9 protein was used, providing a DNAfree alternative suitable for therapeutic applications. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Notably, similar editing improvement was observed when excess gRNA over Cas9 protein was used, providing a DNAfree alternative suitable for therapeutic applications. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|